Here's a news item from the Associated Press: BOISE, Idaho (AP) — A global pharmaceutical company has agreed to pay Idaho $47,000 to settle a fraud lawsuit over a prescription drug for treating multiple sclerosis. Idaho Attorney General Lawrence Wasden announced the settlement Wednesday. Idaho's case is part of bigger lawsuit involved several states and the federal government against EMD Serono, Inc. The company makes Rebif, a prescription drug used to treat relapsing forms of multiple sclerosis. State and federal attorneys alleged the company made inappropriate payments to hundreds of doctors for prescribing Rebif between 2002 and 2009. Of Idaho's share, more than $18,000 will go to the state Medicaid program as restitution, while the additional $28,000 will go into the state's general fund. Altogether, the company agreed to pay more than $44.3 million to the federal government and other states.
Betsy Z. Russell covers Idaho news from The Spokesman-Review's bureau in Boise.
P.O. Box 2160, Spokane, WA 99210
Main switchboard: (509) 459-5000 • (800) 338-8801
Newsroom: (509) 459-5400 • (800) 789-0029
Customer service: (800) 338-8801